A Controlled Trial of Trimethoprim–Sulfamethoxazole or Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis carinii Pneumonia in Patients with the Acquired Immunodeficiency Syndrome: AIDS Clinical Trials Group Protocol 021

New England Journal of Medicine

Volumn 327, Issue 26, 1992, Pages 1842-1848

  Hardy, W David ^a   Feinberg, Judith ^c   Finkelstein, Dianne M ^b   Power, Maureen E ^c   he, Weili ^b   Kaczka, Carolyn ^d   Frame, Peter T ^e   Holmes, Martin ^f   Waskin, Hetty ^g   Fass, Robert J ^h   Powderly, William G ⁱ   Steigbigel, Roy T ^j   Zuger, Abigail ^k   Holzman, Robert S ^l  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

ⁱ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j STONY BROOK UNIVERSITY   (United States)

^k ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^l NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COTRIMOXAZOLE; PENTAMIDINE; SULFAMETHOXAZOLE; TRIMETHOPRIM; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MIXTURE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LEUKOPENIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MORALITY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RECURRENT DISEASE; SURVIVAL;

AEROSOLS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COMPARATIVE STUDY; FEMALE; FOLLOW-UP STUDIES; HUMAN; MALE; PENTAMIDINE; PNEUMONIA, PNEUMOCYSTIS CARINII; RANDOM ALLOCATION; RECURRENCE; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL RATE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; ZIDOVUDINE;

EID: 0027053320     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199212243272604     Document Type: Article

References (18)

1. Fauci AS, moderator. The acquired immunodeficiency syndrome: an update. Ann Intern Med 1985; 102: 800–13.
2. Castellano AR, Nettleman MD. Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia. JAMA 1991; 266: 820–4.
3. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1989; 38: Suppl S-5: 1–9.
4. Hughes WT, Kuhn S, Chaudhary S, et al. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1977; 297: 1419–26.
5. Fischl MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 1988; 259: 1185–9.
6. Leoung GS, Feigal DW Jr, Montgomery AB, et al. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia: the San Francisco Community Prophylaxis Trial. N Engl J Med 1990; 323: 769–75.
7. Metroka CE, Jacobus D, Lewis N. Successful chemoprophylaxis for pneumocystis with dapsone or Bactrim. In: Proceedings of the Fifth International Conference on AIDS, Montreal, June 4–9, 1989. Ottawa, Ont.: International Development Research Centre, 1989:196. abstract.
8. Hardy WD, Wolfe PR, Gottlieb MS, Knight S, Mitsuyasu R, Young LS. Long term follow-up of Fansidar prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS. In: Proceedings of the Third International Conference on AIDS, Washington, D.C., June 1–5, 1987. Washington, D.C.: Department of Health and Human Services, 1987:232. abstract.
9. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549–56.
10. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990; 322: 941–9.
11. Fischl MA, Parker CB, Pettinelli C, et al. A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. N Engl J Med 1990; 323: 1009–14.
12. Collier achéal, Bozzette S, Coombs RW, et al. A pilot study of low-dose zidovudine in human immunodeficiency virus infection. N Engl J Med 1990; 323: 1015–21.
13. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: John Wiley, 1981.
14. Mann HB, Whitney DR. On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 1947; 18: 50–60.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.
16. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1–39.
17. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972; 34: 187–220.
18. Hughes WT, Rivera GK, Schell MJ, Thornton D, Lott L. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1987; 316: 1627–32.